Effects of oral versus transdermal estrogen on the growth hormone/insulin-like growth factor I axis in younger and older postmenopausal women: A Clinical Research Center study

Journal of Clinical Endocrinology and Metabolism

Volumn 81, Issue 8, 1996, Pages 2848-2853

  Bellantoni, Michele F ^a   Vittone, Janet ^a   Campfield, Allison T ^b   Bass, Katherine M ^a   Harman, S Mitchell ^b   Blackman, Marc R ^c  

^a JOHNS HOPKINS BAYVIEW MEDICAL CENTER   (United States)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

^c JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CONJUGATED ESTROGEN; ESTRADIOL; ESTRONE; GROWTH HORMONE; GROWTH HORMONE RELEASING FACTOR; MEDROXYPROGESTERONE ACETATE; PRASTERONE SULFATE; SERMORELIN; SOMATOMEDIN BINDING PROTEIN 3; SOMATOMEDIN C; TESTOSTERONE;

ADULT; AGED; AGING; ARTICLE; BODY MASS; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DRUG EFFICACY; ESTROGEN DEFICIENCY; ESTROGEN THERAPY; FEMALE; GROWTH HORMONE BLOOD LEVEL; GROWTH HORMONE RELEASE; HUMAN; ORAL DRUG ADMINISTRATION; POSTMENOPAUSE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TRANSDERMAL DRUG ADMINISTRATION;

ADMINISTRATION, CUTANEOUS; ADMINISTRATION, ORAL; AGED; AGING; CROSS-OVER STUDIES; ESTROGENS; FEMALE; GROWTH HORMONE; GROWTH HORMONE-RELEASING HORMONE; HUMANS; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 3; INSULIN-LIKE GROWTH FACTOR I; MIDDLE AGED; POSTMENOPAUSE;

EID: 0029811814     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.81.8.2848     Document Type: Article

References (31)

1. Rudman D, Vintner MH, Rogers CM, Lubin MF, Fleming GH, Raymond PB. 1981 Impaired growth hormone secretion in the adult population: relation to age and adiposity. J Clin Invest. 67:1361-1369.
2. Clemmons DR, Van Wyk JJ. 1984 Factors controlling blood concentration of somatomedin C. J Clin Endocrinol Metab. 13:113-143.
3. Corpas E, Harman SM, Blackman MR. 1993 Human Growth Hormone and Human Aging. Endocr Rev. 14:20-39.
4. Salomon F, Cuneo RC, Hesp R, Sönksen PH. 1989 The effects of treatment with recombinant human growth hormone on body composition and metabolism in adults with growth hormone deficiency. N Engl J Med. 321:1797-1803.
5. Cuneo RC, Salomon F, Wiles CM, Sönksen PH. 1990 Skeletal muscle performance in adults with growth hormone deficiency. Horm Metab Res. [Suppl 33]4:55-60.
6. Kaufman J-M, Taelman P, Vermeulen A, Vandeweghe M. 1992 Bone mineral status in growth hormone-deficient males with isolated and multiple pituitary deficiencies of childhood onset. J Clin Endocrinol Metab. 74:118-123.
7. Rudman D. 1985 Growth hormone, body composition and aging. J Am Geriatr Soc. 33:800-807.
8. Ho KY, Evans WS, Blizzard RM, et al. 1987 Effects of sex and age on 24-hour profile of growth hormone secretion in men: importance of endogenous estradiol concentrations, j Clin Endocrinol Metab. 64:51-58.
9. Ho KY, Weissberger AJ. 1990 Secretory patterns of growth hormone according to sex and age. Horm Res. [Suppl 4]33:7-11.
10. Kelly JJ, Rajkovic IA, O'Sullivan AJ, Sernia C, Ho K. 1993 Effects of different oral oestrogen formulations on insulin-like growth factor-1, growth hormone and growth hormone binding protein in post-menopausal women. Clin Endocrinol (Oxf). 39(5):561-567.
11. Dawson-Hughes B, Stern D, Goldman J, Reichlin S. 1986 Regulation of growth hormone and somatomedin-C secretion in postmenopausal women: effect of physiological estrogen replacement therapy. J Clin Endocrinol Metab. 63:424-429.
12. Lieberman SA, Mitchell AM, Marcus R, Hintz RL, Hoffman AR. 1994 The insulin-like growth factor I generation test - resistance to growth hormone with aging and estrogen replacement therapy. Horm Metab Res. 26:229-233.
13. Weissberger AJ, Ho KKY, Lazarus LJ. 1991 Contrasting effects of oral and transdermal routes of estrogen replacement therapy on 24-hour growth hormone (GH) secretion, insulin-like growth factor I, and GH-binding protein in postmenopausal women. J Clin Endocrinol Metab. 72:374-381.
14. Bellantoni MF, Harman SM, Cho D, Blackman MR. 1991 Effects of progestinopposed transdermal estrogen administration on GH and IGF-I in postmenopausal women of different ages. J Clin Endocrinol Metab. 72:172-178.
15. Ho KKY, Weissberger AJ. 1992 Impact of short-term estrogen administration on growth hormone secretion and action: distinct route-dependent effects on connective and bone tissue metabolism. J Bone Miner Res. 7:821-827.
16. Slowinska-Srzednicka J, Zgliczynski S, Jeske W. 1992 Transdermal 17 beta estradiol combined with oral progestogen increases plasma levels of insulinlike growth factor I in postmenopausal women. J Endocrinol Invest. 15(7):533-538.
17. Bellantoni MF, Harman SM, Cullins VE, Engelhardt SM, Blackman MR. 1991 Transdermal estradiol with oral progestin: biological and clinical effects in younger and older postmenopausal women. J Gerontol. 46:M216-M222.
18. Corpas E, Harman SM, Piñeyro MA, Roberson R, Blackman MR. 1992 GHRH 1-29 twice daily reverses the decreased GH and IGF-I levels in old men. J Clin Endocrinol Metab. 75:530-535.
19. Hintz RL, Lui F, Marshall LB, Chang D. 1980 Interaction of somatomedin-C with an antibody directed against the synthetic C-peptide region of insulin-like growth factor I. J Clin Endocrinol Metab. 50:405-407.
20. Blum WF, Ranke MB, Kietzmann K, Gauggel E, Zeisel HJ, Bierich JR. 1990 A specific radioimmunoassay for the growth hormone (GH)-dependent somatomedin-binding protein: its use for diagnosis of GH deficiency. J Clin Endocrinol Metab. 70:1292-1298.
21. Wu CH, Lundy LE. 1971 Radioimmunoassay of plasma estrogens. Steroids. 18:91-111.
22. Abraham GE, Buster JE, Lucas LA. 1972 Chromatographic separation of steroid hormones for use in radioimmunoassay. Anal Lett. 5:509-13.
23. Cutler GB, Glenn M, Bush M, Hodgen GD, Graham CE, Loriaux DL. 1978 Adrenarche: a survey of rodents, domestic animals and primates. Endocrinology. 103:2112-2118.
24. Merriam GR, Wachter KW. 1982 Algorithms for the study of episodic hormone secretion. Am J Physiol. 243:E310-E318.
25. Prestwood KM, Pilbeam CC, Burleson JA, et al. 1994 The short-term effects of conjugated estrogen on bone turnover in older women. J Clin Endocrinol Metab. 79:366-371.
26. Blackman MR, Elahi D, Human SM. 1995 Endocrinology and aging. In: DeGroot LJ, ed. Endocrinology. 3rd ed. New York: Grune and Stratton; 2702-2730.
27. Chetkowski RJ, Meldrum DR. 1986 Biologic effects of transdermal estradiol. N Engl J Med. 314:1615-1620.
28. Krattenmacher R, Knauthe R, Parczyk K, Walker A, Hilgenfeldt U, Fritzemeier KH. 1994 Estrogen action on hepatic synthesis of angiotensinogen and IGF-I: direct and indirect estrogen effects. J Steroid Biochem Mol Biol. 48:207-214.
29. Friend KE, Hartmann ML, Pezzoli SS, Clasey JL, Thorner MO. 1996 Both oral and transdermal estrogen replacement increase GH release in postmenopausal women: a clinical research center study. J Clin Endocrinol Metab. 81:2250-2256.
30. Lang I, Schernthaner G, Pietschmann P, Kurz R, Stephenson JM, Templ M. 1987 Effects of sex and age on growth hormone response to growth hormone-releasing hormone in healthy individuals. J Clin Endocrinol Metab. 65:535-540.
31. Lufkin EG, Wahner HW, O'Fallon WM, et al. 1992 Treatment of postmenopausal osteoporosis with transdermal estrogen. Ann Intern Med. 117:1-9.